CYP7A1 and primary biliary cholangitis: Serum C4, a direct intermediate product of CYP7A1 in the process of BA synthesis and a marker for BA synthesis [25, 26], was hence significantly decreased in PBC-AIH OS patients, especially cirrhotic patients.